These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 9256020)

  • 1. Evaluation of the safety of cantastim in normal humans.
    Olinescu A; Radu LD; Dolganiuc A; Istrate N; Muni IA
    Roum Arch Microbiol Immunol; 1996; 55(3):183-92. PubMed ID: 9256020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and in vitro effect of Cantastim, an immunomodulatory agent extracted from a highly pathogenic Pseudomonas aeruginosa strain.
    Olinescu A; Hristescu S; Sålågeanu A; Manda G; Neagu M
    Neoplasma; 1991; 38(1):119-28. PubMed ID: 1901383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of CD14 expression on human granulocytes by a bacterial product "Cantastim" derived from Pseudomonas aeruginosa.
    Radu DL; Dolganiuc A; Istrate N; Szegli G; Olinescu A
    Roum Arch Microbiol Immunol; 1997; 56(1-2):47-53. PubMed ID: 9558975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Normalization of immune function following therapy with Cantastim in a case of chronic T-cell lymphatic leukemia (CTLL)].
    Olinescu A; Hristescu S; Sălăgeanu A; Petrovici A; Grigoriu G
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1988; 33(3):281-8. PubMed ID: 3249900
    [No Abstract]   [Full Text] [Related]  

  • 5. Experimental studies on bacterial product CANTASTIM derived from Pseudomonas aeruginosa with immunomodulatory properties. IV. Tyrosine phosphorylation as an effect of stimulation on different cell populations.
    Onu A; Stefanescu M; Matache C; Salageanu A; Istrate N; Szegli G
    Roum Arch Microbiol Immunol; 1997; 56(1-2):37-45. PubMed ID: 9558974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental studies on the bacterial product CANTASTIM derived from Pseudomonas aeruginosa. III. Suppression of lipopolysaccharide-induced tumor necrosis factor alpha: are the lipid components involved?
    Salageanu A; Ceacareanu B; Istrate N; Szegli G
    Roum Arch Microbiol Immunol; 1997; 56(1-2):27-35. PubMed ID: 9558973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental studies on bacterial product cantastim derived from Pseudomonas aeruginosa. VII. Activation of immune cells of healthy controls and cancer patients.
    Caras I; Serbanescu IF; Grigorescu A; Salageanu A
    Roum Arch Microbiol Immunol; 2005; 64(1-4):5-10. PubMed ID: 17405308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental studies on bacterial product CANTASTIM derived from Pseudomonas aeruginosa. II. Protective effect in Salmonella typhimurium infection.
    Salageanu A; Ceacareanu B; Popescu D; Istrate N; Szegli G
    Roum Arch Microbiol Immunol; 1997; 56(1-2):17-26. PubMed ID: 9558972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulation activity of a Pseudomonas aeruginosa extract--cantastim.
    Neguţ E; Szegli G; Peligrad I; Matache C; Olinescu A; Marx A
    Arch Roum Pathol Exp Microbiol; 1985; 44(4):323-35. PubMed ID: 3939398
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental studies on the bacterial product CANTASTIM derived from Pseudomonas aeruginosa. V. Protective effect in endotoxin shock.
    Salageanu A; Szegli G
    Roum Arch Microbiol Immunol; 1999; 58(2):101-9. PubMed ID: 11845449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine.
    Cooper CL; Davis HL; Morris ML; Efler SM; Krieg AM; Li Y; Laframboise C; Al Adhami MJ; Khaliq Y; Seguin I; Cameron DW
    Vaccine; 2004 Aug; 22(23-24):3136-43. PubMed ID: 15297066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine profiling by multiplex immunoassay as an effective approach to assess immunomodulatory activity of bacterial product CANTASTIM.
    Lerescu L; Tucureanu C; Caraş I; Sălăgeanu A
    Roum Arch Microbiol Immunol; 2006; 65(1-2):53-8. PubMed ID: 17877111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Environmental adjuvants, apoptosis and the censorship over autoimmunity.
    Rovere-Querini P; Manfredi AA; Sabbadini MG
    Autoimmun Rev; 2005 Nov; 4(8):555-60. PubMed ID: 16214095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental studies on bacterial product cantastim derived from Pseudomonas aeruginosa. VI. Protection in tolerant mice.
    Caraş I; Sălăgeanu A
    Roum Arch Microbiol Immunol; 2004; 63(1-2):47-62. PubMed ID: 16295320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-Pseudomonas aeruginosa antibodies, circulating immune complexes, and anticytoplasm antibodies of neutrophils in patients with cystic fibrosis with and without Pseudomonas aeruginosa colonization].
    Chiappini E; Taccetti G; Campana S; Turchini S; Marianelli L
    Pediatr Med Chir; 2001; 23(1):27-30. PubMed ID: 11486418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of vaccine technology to prevention of Pseudomonas aeruginosa infections.
    Pier G
    Expert Rev Vaccines; 2005 Oct; 4(5):645-56. PubMed ID: 16221066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of biological activity and safety of recombinant canine erythropoietin with that of recombinant human erythropoietin in clinically normal dogs.
    Randolph JF; Stokol T; Scarlett JM; MacLeod JN
    Am J Vet Res; 1999 May; 60(5):636-42. PubMed ID: 10328437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Ratjen F; Walter H; Haug M; Meisner C; Grasemann H; Döring G
    Pediatr Pulmonol; 2007 Mar; 42(3):249-55. PubMed ID: 17243185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and tolerance of repeated anesthesia with CI 581 (Ketamine) in monkeys.
    Bree MM; Feller I; Corssen G
    Anesth Analg; 1967; 46(5):596-600. PubMed ID: 4964042
    [No Abstract]   [Full Text] [Related]  

  • 20. Short- and long-term effects of T-cell modulating agents in experimental autoimmunity.
    Mellergård J; Havarinasab S; Hultman P
    Toxicology; 2004 Mar; 196(3):197-209. PubMed ID: 15036746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.